blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4244248

EP4244248 - FAB HIGH MANNOSE GLYCOFORMS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.08.2023
Database last updated on 01.01.2025
FormerThe international publication has been made
Status updated on  21.05.2022
Formerunknown
Status updated on  19.11.2021
Most recent event   Tooltip22.11.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2023/38]
Inventor(s)01 / JOERIS, Klaus
82377 Penzberg / DE
02 / OEZDEN, Neslihan
82377 Penzberg / DE
03 / RICHTER, Wolfgang
4070 Basel / CH
04 / SCHMIDT, Britta
82377 Penzberg / DE
05 / HOFMANN, Carsten
4070 Basel / CH
06 / LAU, Wilma
82377 Penzberg / DE
07 / STAACK, Roland
82377 Penzberg / DE
 [2023/38]
Representative(s)Skolaut, Alexander
Roche Diagnostics GmbH
Patentabteilung
LPAA....6164
Nonnenwald 2
82377 Penzberg / DE
[N/P]
Former [2023/38]Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
Application number, filing date21802364.604.11.2021
[2023/38]
WO2021EP80692
Priority number, dateEP2020020780416.11.2020         Original published format: EP 20207804
[2023/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022101088
Date:19.05.2022
Language:EN
[2022/20]
Type: A1 Application with search report 
No.:EP4244248
Date:20.09.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 19.05.2022 takes the place of the publication of the European patent application.
[2023/38]
Search report(s)International search report - published on:EP19.05.2022
ClassificationIPC:C07K16/18, A61K39/00
[2023/38]
CPC:
C07K16/18 (EP,IL,KR,US); C07K16/2881 (US); A61K2039/505 (EP,IL,KR,US);
C07K2317/14 (EP,IL,KR); C07K2317/31 (US); C07K2317/41 (EP,IL,KR,US);
C07K2317/55 (EP,IL,KR,US); C07K2317/94 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/38]
Validation statesMA22.05.2023
TitleGerman:FAB-GLYCOFORMEN MIT HOHEM MANNOSEGEHALT[2023/38]
English:FAB HIGH MANNOSE GLYCOFORMS[2023/38]
French:GLYCOFORMES FAB À HAUTE TENEUR EN MANNOSE[2023/38]
Entry into regional phase22.05.2023National basic fee paid 
22.05.2023Designation fee(s) paid 
22.05.2023Examination fee paid 
Examination procedure22.05.2023Examination requested  [2023/38]
22.05.2023Date on which the examining division has become responsible
21.12.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
22.11.2023Renewal fee patent year 03
21.11.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]EP1960428  (HOFFMANN LA ROCHE [CH]) [X] 1,3,5,18,19 * the whole document * [A] 2,4,6-17,20;
 [A]  - VAN DE BOVENKAMP FLEUR S. ET AL, "The Emerging Importance of IgG Fab Glycosylation in Immunity", US, vol. 196, no. 4, doi:10.4049/jimmunol.1502136, ISSN 0022-1767, (20160215), pages 1435 - 1441, THE JOURNAL OF IMMUNOLOGY, URL: https://www.jimmunol.org/content/jimmunol/196/4/1435.full.pdf, XP055797847 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.4049/jimmunol.1502136
 [XI]  - HUANG L ET AL, "Impact of variable domain glycosylation on antibody clearance: An LC/MS characterization", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, AMSTERDAM, NL, vol. 349, no. 2, doi:10.1016/J.AB.2005.11.012, ISSN 0003-2697, (20060215), pages 197 - 207, (20060215), XP024941990 [X] 1,3,5,18,19 * the whole document * [I] 2,4,6-17,20

DOI:   http://dx.doi.org/10.1016/j.ab.2005.11.012
 [A]  - A. M. GOETZE ET AL, "High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans", GLYCOBIOLOGY, (20110701), vol. 21, no. 7, doi:10.1093/glycob/cwr027, ISSN 0959-6658, pages 949 - 959, XP055169019 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1093/glycob/cwr027
by applicantUS4676980
 EP0307247
 US4816567
 EP0404097
 WO9301161
 WO9316185
 US5571894
 US5587458
 WO9725428
 US5731168
 US5770429
 US5821337
 WO9850431
 US5869046
 US6075181
 US6150584
 US6248516
 US6982321
 US7041870
 US7087409
 US7189826
 US2007061900
 US2008069820
 EP1960428
 US7527791
 WO2009089004
 WO2011034605
 EP1960428
 WO2015095539
 EP3356400
    - ZHANG et al., Drug Discovery Today, (20160000), vol. 21, pages 740 - 765
    - HIGEL et al., European Journal of Pharmaceutics and Biopharmaceutics, (20160000), vol. 100, pages 94 - 100
    - BIERMANN et al., Lupus, (20160000), vol. 25, pages 934 - 942
    - JEFFERIS, Nature, (20090000), vol. 8, pages 226 - 234
    - MILLWARD et al., Biologicals, (20080000), vol. 36, pages 41 - 47
    - FINKEBANKS, "UW Tacoma Digital Commons", SIAS Faculty Digital Publications, URL: https://diitalcommons.tacoma.uw.edu/iaspub/825
    - BOVENKAMP et al., J.Immunology, (20160000), vol. 196, pages 1435 - 1441
    - TACHIBANA et al., Cytotechnology, (19940000), vol. 16, pages 151 - 157
    - HOSSLER et al., Glycobiology, (20090000), vol. 19, no. 9, pages 936 - 949
    - EHRET et al., Biotechnol & Bioeng, (20190000), vol. 116, pages 816 - 830
    - FAN et al., Biotech & Bioeng, (20150000), vol. 112, no. 3, pages 521 - 535
    - HUANG et al., Anal. Biochem., (20060000), vol. 349, pages 197 - 207
    - ST AMAND et al., Biotechnol Bioeng, (20140000), vol. 111, no. 10, pages 1957 - 70
    - FLATMAN et al., J. Chromatogr. B, (20070000), vol. 848, pages 79 - 87
    - MORRISON et al., P.N.A.S, (19840000), vol. 81, pages 6851 - 6855
    - ALMAGROFRANSSON, Front. Biosci., (20080000), vol. 13, pages 1619 - 1633
    - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329
    - QUEEN et al., Proc. Nat'l Acad. Sci. USA, (19890000), vol. 86, pages 10029 - 10033
    - DALL'ACQUA et al., Methods, (20050000), vol. 36, pages 61 - 68
    - PADLAN, Mol. Immunol., (19910000), vol. 28, pages 489 - 498
    - KLIMKA et al., Br. J. Cancer, (20000000), vol. 83, pages 252 - 260
    - PRESTA et al., J. Immunol., (19930000), vol. 151, page 2623
    - CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285
    - BACA et al., J. Biol. Chem., (19970000), vol. 272, pages 10678 - 10684
    - ROSOK et al., J. Biol. Chem., (19960000), vol. 271, pages 22611 - 22618
    - VAN DIJKVAN DE WINKEL, Curr. Opin. Pharmacol., (20010000), vol. 5, pages 368 - 74
    - LONBERG, Curr. Opin. Immunol., (20080000), vol. 20, pages 450 - 459
    - LONBERG, Nat. Biotech., (20050000), vol. 23, pages 1117 - 1125
    - KOZBOR, J. Immunol., (19840000), vol. 133, page 3001
    - BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63
    - TUTT et al., J. Immunol., (19910000), vol. 147, page 60
    - LI et al., Proc. Natl. Acad. Sci. USA, (20060000), vol. 103, pages 3557 - 3562
    - NI, Xiandai Mianyixue, (20060000), vol. 26, no. 4, pages 265 - 268
    - VOLLMERSBRANDLEIN, Histology and Histopathology, (20050000), vol. 20, no. 3, pages 927 - 937
    - VOLLMERSBRANDLEIN, Methods and Findings in Experimental and Clinical Pharmacology, (20050000), vol. 27, no. 3, pages 185 - 91
    - HOLLIGERHUDSON, Nature Biotechnology, (20050000), vol. 23, pages 1126 - 1136
    - HUDSON et al., Nat. Med., (20030000), vol. 9, pages 129 - 134
    - HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448
    - GRUBER et al., J. Immunol., (19940000), vol. 152, pages 5368 - 315
    - MILSTEINCUELLO, Nature, (19830000), vol. 305, page 537
    - ATWELL et al., J. Mol. Biol., (19970000), vol. 270, page 26
    - BRENNAN et al., Science, (19850000), vol. 229, page 81
    - KOSTELNY et al., J. Immunol., (19920000), vol. 148, no. 5, pages 1547 - 1553
    - LIU et al., J. Pharmaceutical Sciences, (20150000), vol. 104, pages 1866 - 1884
    - MONTREUIL, Polysaccharides in Medicinal Applications, (19960000), vol. 273-327
    - FAN et al., Biotechnol. Bioeng., (20150000), vol. 112, no. 3, pages 521 - 535
    - BARNESSATO, Cell, (19800000), vol. 22, page 649
    - GRAHAM et al., J.Gen.Virol., (19770000), vol. 36, page 59
    - BAUMANN et al., J.Cell Biol., (19800000), vol. 85
    - MATHER et al., Annals N.Y.Acad.Sci., (19820000), vol. 383, page 44
    - SIMONSENLEVINSON, P.N.A.S., (19830000), vol. 80, pages 2495 - 2499
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.